We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Genticel Completes Procervix Phase II Study Enrollment Ahead of Schedule

News   Nov 15, 2014

 
Genticel Completes Procervix Phase II Study Enrollment Ahead of Schedule
 
 
 

RELATED ARTICLES

Probiotic Gives Long-standing Protection Against Childhood Eczema

News

Giving a probiotic supplement to pregnant mothers and their infants significantly reduces the chances of a child developing eczema for the first 11 years of their life.

READ MORE

Promise for an HIV Vaccine

News

An experimental vaccine strategy against HIV has been shown to work in non-human primates.

READ MORE

Vaccination May Reduce Flu Severity in Vaccinated Patients

News

Vaccination may reduce the severity of the flu in vaccinated but still infected patients.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE